Optos plc, unveils Silverstone, a Combined Ultra-widefield Retinal Imaging Device and UWF-Guided Swept Source OCT for the Ophthalmic Market

12 October 2019

Optos plc, the leading medical retinal imaging company, part of Nikon Corporation, is pleased to announce the launch of Silverstone at the American Academy of Ophthalmology, San Francisco, CA.

Silverstone is the first of its kind, combining world-leading ultra-widefield retinal imaging with integrated, image-guided, swept source OCT.  Silverstone produces a 200° single capture optomap® image with guided OCT allowing advanced OCT imaging anywhere across the retina, from posterior pole to far periphery.  This provides unparalleled UWF guided multimodal imaging in support of detection, investigation and monitoring of retinal disease.

Silverstone provides greater imaging functionality and expands the Company’s product portfolio for ophthalmic markets.  It combines colour, autofluorescence (AF), fluorescein (FA) and Indocyanine Green (ICG) angiography with Swept Source OCT imaging capabilities.  A comprehensive exam that includes an ultra-widefield optomap® image has been shown in clinical studies to enhance pathology detection and disease management, as well as to improve clinic flow.  Now by integrating swept source OCT, Silverstone further facilitates examination of the retina from vitreous through the choroidal-scleral interface and helps guide treatment decisions.

Silverstone SS OCT

David M. Brown, MD from Retina Consultants of Houston in Houston, TX, remarked, “Silverstone is very exciting.  It’s definitely the best device we’ve seen for choroidal imaging, and the UWF-guided OCT makes it easy to scan lesions even in the far periphery.”

Robert Kennedy, CEO of Optos, commented:  I am delighted to introduce Silverstone, our newest offering for the ophthalmic market. The integration of UWF guided swept source OCT with optomap gives eye care professionals unprecedented capability to manage retinal disease.  For the first time, doctors can capture OCT scans of peripheral lesions something not readily achievable with traditional OCTs.  We are extremely excited to introduce this comprehensive solution for patient imaging to our customers.

Further product details are available at www.optosnextgen.com.

Enquiries:

Leslie Amodei, VP, Global Marketing Tel: 508-787-1414

Comments are closed.